DFDA

Bilateral Adrenalectomy

Treatment for Cushings Syndrome

Effectiveness
98%
Safety Score
60%
Clinical Trials
1
Participants
5K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
60
DangerousModerateSafe
Treatment Details
Time to Effect
immediate
Treatment Duration
one-time procedure, lifelong medication
Evidence Quality
HIGH
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$1,500
Monitoring:$2,500
Side Effect Mgmt:$1,000
Total Annual:$5,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
ICER
$80,000/QALY
QALYs Gained
0.9
Outcome-Based Costs
Cost per Responder
$5,102
Cost per Remission
$5,102
Bilateral Adrenalectomy Outcomes

for Cushings Syndrome

Efficacy Outcomes
Overall Effectiveness
+98%
Response Rate
+98%
Remission Rate
+98%
Common Side Effects
Surgical complications (bleeding, infection)
+8%
Lifelong adrenal insufficiency
+100%
Nelson's Syndrome (for pituitary disease)
+20%

Sources:

oup.com
nih.gov
researchgate.net

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
1 active trial recruiting for Bilateral Adrenalectomy in Cushings Syndrome

Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism

NCT05368090RECRUITINGNA
View Study
60 participants
INTERVENTIONAL
Bergen, Norway
Started: Jun 3, 2022